New approach improves the reliability of detecting cardiac risk in ECG data from consumer devices
In new study, researchers show that genome sequencing provides more answers than traditional genetic testing.
Now is the time to gather forces to focus not on short-term wins and gains but on creating enduring long-term value for all.
With a more inclusive reference data set, scientists and doctors will be able to more easily spot clinically relevant genetic variants for all people.
One major obstacle to precision medicine for all? The cost of sequencing each person’s genome. New sequencing startups could change that.
Handheld ultrasound devices could eventually become as common as stethoscopes, and might even be used by patients themselves to send images to doctors from home.